Jennifer Bergeron, MD

Assistant Professor
Nephrology Fellowship Program Director

Organization:

West Virginia University School of Medicine

Department:

Medicine

Classification:

Faculty

• MD, Tufts University School of Medicine, Boston, MA, 2018

Bergeron J, Marchese C, Jensen C, Meagher S, Kennedy AG, Tompkins B, Cheung KL. Nephrology providers' perspective and use of mortality prognostic tools in dialysis patients. BMC Nephrol. 2024 Nov 26;25(1):425. doi: 10.1186/s12882-024-03861-y. PMID: 39587463.

Bergeron, Jennifer. “Perspectives of Polypharmacy and Its Effects on Quality of Life by Patients on Dialysis”. Kidney News 1.63(2024):31. https://www.kidneynews.org/view/journals/kidney-news/16/3/article-p31_20.xml

Bergeron, J. and Triozzi, J. “Heart Failure Devices.” NephMadness 2023, AJKD Blog. March 1 2023. https://ajkdblog.org/2023/03/01/nephmadness-2023-heart-failure-devices-region/

Bergeron, J., Barrett, T., Repp, A. (2022). Culture negative endocarditis with Tropheryma whipplei. Annals of Internal Medicine: Clinical Cases. DOI: 10.7326/aimcc.2022.0277

Bergeron, J., Mahurin, C., Koundakjian, D., and Tsai, M. SGLT2 Inhibitors – A Cardiac vs Renal Perspective. Green Mountain Medicine Podcast. 2020. https://open.spotify.com/episode/2PoXbGaXB30brp3qgbCdPd

Snow, S., Bacon, E., Bergeron, J., Katzman, D., Wilhelm, A., Lewis, O., Syangtan D., Calkins, A., Archambault, L., Anacker,M., Schlax, P.J. (2020). Transcript decay mediated by RNase III in Borrelia burgdorferi. Biochemical and Biophysical Research Communications, 529(2), 386-391. DOI: 10.1016/j.bbrc.2020.05.201.

Archambault, L., Borchert, J.S., Bergeron, J.M., Snow, S.M., & Schlax, P.J. (2013). Measurements of mRNA Degradation in Borrelia burgdorferi. Journal of Bacteriology, 195(21), 4879-4887. DOI: 10.1128/JB.00659-13

Posters:

Khan, S, Bergeron, J. “Lenalidomide-Induced Electrolyte Abnormalities: An Unconfounded Case of Acute Severe Refractory Hypocalcemia”, ASN Kidney Week, Texas, November 8, 2025. Poster.  
 
McCoy, M, Jafary, Z, Hasan, I, Bergeron, J. “A New Finding in Psoriatic Nephropathy”, ASN Kidney Week, Texas, November 6, 2025. Poster.  
 
Nahhas, P, Renfrow, A, Condiles, N, Bergeron, J. “IgA-IRGN Secondary to Graulicatella adjacens Bacteremia” ASN Kidney Week, Texas, November 6, 2025. Poster.  
 
Linder, A, Bergeron, J. “Death by Overestimation: Measuring Kidney function in an Adult Male with Bilateral Hip Disarticulation” ACP WV Chapter Annual Scientific Meeting, WV, October 2, 2025. Poster.  
 
Neuman, M, Bradner, A, Bergeron, J. “Challenges in Identifying and Managing Lithium-Induced Arginine Vasopressin Resistance (AVP-R)”, ASN Kidney Week, California, October 24, 2024. Poster.  

Bergeron, J.M., Damon, C., Meagher, S., and Cheung, K.L (2022). “Validity and Practice Patterns of Mortality Risk Prediction Tools in Dialysis Patients”, ASN Kidney Week, Florida, Nov 3 2022. Poster.

Bergeron, J.M., Damon, C., and Cheung, K.L (2020). “Practice Patterns of Mortality Risk Prediction Tools in the Vermont Dialysis Population”, Vermont Chapter ACP Scientific Meeting, Vermont, September 25 2020. Poster.

Bergeron, J.M., Snow, S.M., Archambault, L. & Schlax, P.J. (2013). “mRNA Decay in Borrelia burgdorferi”, Northeast Regional IDeA Conference (INBRE), Delaware, August 2013. Poster.

Abstracts:

Linder, A, Bergeron, J. “Tirzepatide: Pillar of Diabetic Kidney Disease Therapy or Wrecking Ball?” ASN’s 2025 Abstract Supplement, October 30, 2025. 

Bergeron, J., Fogo, A., and Lewis, J. (2022). “The gut: A giant nephron!”, ASN’s 2022 Abstract Supplement, Oct 14, 2022.

Principle Investigator:

• Site Principle Investigator: GlomCon Foundation Research Study Collaboration, CREATE, REIGNITE, GIGANTIC, December 2025 – Present
• Site Principle Investigator: Podocytopathies Study, Boehringer Ingelheim (BI 1434-0017 and -0027), October 2025 – Present 
• “Targeting Dry Weights in the Hospital.” West Virginia University, Morgantown WV. March 2024 – Present
• “Predicting technique failure in peritoneal dialysis.” Vanderbilt University Medical Center, Nashville TN. 2022 – 2023
• “Validity and utility of mortality risk prediction tools in the Vermont dialysis population.” University of Vermont Medical Center, Burlington VT. 2019 – Present

Study Personnel:

• Site Sub-Investigator: IgAN Study, Takeda (TAK-079-3001), March 2025 – Present 
• “Outcomes of desensitization in living donor kidney transplant recipients”. Vanderbilt University Medical Center, Nashville TN. 2022 – 2023

Research Assistant:

• “Caveolin 3 mutations and regulation of the insulin receptor in lipotoxic cardiomyopathy.” Maine Medical Center Research Institute, Portland ME. Summer 2015
• “mRNA processing in the alpha and rpsO-pnp operon of Borrelia burgdorferi is mediated by RNase III.” Bates College, Lewiston ME. Senior Thesis and Defense for Bachelor of Science in Biological Chemistry. 2013 – 2014
• “mRNA degradation in Borrelia burgdorferi.” Bates College, Lewiston ME. Summer 2013
• “Characterization of neuromodulators in Helisoma trivolvis.” Mount Desert Island Biological Laboratory, Bar Harbor ME. Summer 2012
• “Translational regulation in diverse prokaryotes.” Bates College, Lewiston ME. Summer 2011

Quality Improvement Experiences:

• “Why Home?” – Home Dialysis Project. Vanderbilt University Medical Center, Nashville TN. 2021 – 2023
• “Testing for UTIs in Adults without Urinary Symptoms: A High Value Care Case Analysis.” The University of Vermont, Department of Medicine, Burlington VT. 2020 – 2021
• “Transitions of care at hospital discharge- to call or not to call?” The University of Vermont Medical Center, Department of Internal Medicine. 2019 – 2020

Medical Specialties

• Nephrology/Kidney Disease

Special Training

• Fellowship, Nephrology
  Vanderbilt University Medical Center, Nashville TN, 2023
• Residency, Internal Medicine
  The University of Vermont Medical Center, Burlington VT, 2021